[HTML][HTML] Level of Non-high-density-lipoprotein Cholesterol and Its Related Factors in Chinese Han Students 中國漢族學生非高密度脂蛋白膽固醇水平及其相關因素

YL Fang, L Liang, JF Fu, CX Gong, F Xiong… - HK J Paediatr (new …, 2013 - hkjpaed.org
diabetes mellitus, dyslipidemia is a component of metabolic syndrome and associated with
an increasing incidence of coronary heart disease. … /lipoprotein had different results. Study by …

Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the C …

S Kannan, KM Pantalone, S Matsuda… - … of diabetes, 2016 - Wiley Online Library
… -1a) and cardiovascular outcomes.16, 17 The Liraglutide effect and action in diabetes:
Evaluation of cardiovascular outcome results (LEADER) trial evaluated cardiovascular safety of …

… or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24‐week, post‐marketing SUNSHINE study: 沙格列汀在中国2 型糖尿病患者中 …

W Gu, L Liang, S Wang, Y Wang, Y Wu… - … of diabetes, 2016 - Wiley Online Library
… for 24 weekS, in patients with type 2 diabetes mellitus wHo are treatment naïve or have …
Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus) study, 613 of 8280 patients

… glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes: 在新诊断的2 …

KM Pantalone, AD Misra‐Hebert, TM Hobbs… - … of diabetes, 2018 - Wiley Online Library
… greater risk of death, with similar results observed for the association of the … cardiovascular
outcomes. For example, recent studies with empagliflozin (a sodium–glucose cotransporter 2

Association between type 2 diabetes mellitus and disability: What is the contribution of diabetes risk factors and diabetes complications? 2 型糖尿病与残疾之间的关系 …

M Tabesh, JE Shaw, PZ Zimmet… - … of diabetes, 2018 - Wiley Online Library
type 2 diabetes and disability in Mauritius and to assess the extent to which the effect of
diabetes is explained by diabetes risk … Similar to the findings of the present study, in the AusDiab …

… and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction: 对亚洲2 型糖尿病患者 …

TWL Lau, KEK Tan, JCJ Choo, TG Ng… - … of Diabetes, 2018 - Wiley Online Library
… and metabolic syndrome in addition to eGFR and ACR.24 These findings have subsequently
been confirmed in several meta-analyses regarding the importance of metabolic syndrome …

Brain atrophy in middle‐aged subjects with Type 2 diabetes mellitus, with and without microvascular complications: 合并或者不合并微血管并发症的中年2 型糖尿病受试 …

F Fang, YF Zhan, YY Zhuo, DZ Yin, KA Li… - … of Diabetes, 2018 - Wiley Online Library
… with a marked increase in the prevalence of Type 2 diabetes mellitus (T2DM).1 This rapid rise
in … Earlier diagnosis results in longer disease duration and long-term suboptimal metabolic

HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics: 亚洲2 型糖尿病患者的HbA1c 以及收缩压的变异性与糖尿病视网膜病变之间 …

V Foo, J Quah, G Cheung, NC Tan… - … of diabetes, 2017 - Wiley Online Library
… The findings of the present study are similar to an earlier report … metabolic memory”
phenomenon including oxidative stress.37 However, the reason for the discrepancy between …

Anthropometric discriminators of type 2 diabetes among White and Black American adults: 在白种以及黑种美国成年人中可以鉴别2 型糖尿病的人体测量学指标

DS Hardy, DT Stallings, JT Garvin… - … of diabetes, 2017 - Wiley Online Library
… our findings back to the parent White and Black populations. … dyslipidemia, metabolic
syndrome, and coronary heart diseaseType 2 diabetes mellitus is a metabolic condition that …

… of Jinlida in patients with inadequately controlled type-2 diabetes and dyslipidemia under life style intervention (ENJOY LIFE Study) 合并血脂异常的2 型糖尿病患者在 …

Y Zhang, W Wang, G Ning - Journal of diabetes, 2015 - search.ebscohost.com
… efficacy and safety of Jinlida in type-2 diabetes with inadequately control and dyslipi… findings
from this study will shed light on the efficacy of Jinlida in treatment of patients with metabolic